Article
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
4 Jan 2023
Abstract excerpt
Background: Hepatocellular carcinoma (HCC) is one of the most common aggressive malignancies with increasing incidence worldwide. The oncogenic roles of transcription factors (TFs) were increasingly recognized in various cancers. This study aimed to develop a predicting signature based on TFs for the prognosis and treatment of HCC. Methods: Differentially expressed TFs were screened from data in the TCGA-LIHC and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
